CS219391A3 - Pyrazolidinone derivatives and a pharmaceutical comprised therein - Google Patents

Pyrazolidinone derivatives and a pharmaceutical comprised therein Download PDF

Info

Publication number
CS219391A3
CS219391A3 CS912193A CS219391A CS219391A3 CS 219391 A3 CS219391 A3 CS 219391A3 CS 912193 A CS912193 A CS 912193A CS 219391 A CS219391 A CS 219391A CS 219391 A3 CS219391 A3 CS 219391A3
Authority
CS
Czechoslovakia
Prior art keywords
group
formula
carbon atoms
phenyl
alkyl
Prior art date
Application number
CS912193A
Other languages
Czech (cs)
English (en)
Inventor
Raymond Frank Brown
James Jeffry Howbert
Karen Lynn Lobb
David Andrew Neel
Jon Kevin Reel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS219391A3 publication Critical patent/CS219391A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS912193A 1990-07-17 1991-07-15 Pyrazolidinone derivatives and a pharmaceutical comprised therein CS219391A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55348990A 1990-07-17 1990-07-17

Publications (1)

Publication Number Publication Date
CS219391A3 true CS219391A3 (en) 1992-02-19

Family

ID=24209587

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912193A CS219391A3 (en) 1990-07-17 1991-07-15 Pyrazolidinone derivatives and a pharmaceutical comprised therein

Country Status (19)

Country Link
EP (1) EP0467614A1 (ja)
JP (1) JPH04230367A (ja)
KR (1) KR960005950B1 (ja)
CN (1) CN1032000C (ja)
AU (2) AU644190B2 (ja)
BR (1) BR9103042A (ja)
CA (1) CA2046672A1 (ja)
CS (1) CS219391A3 (ja)
FI (1) FI913431A7 (ja)
HU (1) HUT58296A (ja)
IE (1) IE912489A1 (ja)
IL (1) IL98785A (ja)
MX (1) MX9100164A (ja)
NO (1) NO912772L (ja)
NZ (1) NZ238912A (ja)
PT (1) PT98323A (ja)
RU (1) RU2076100C1 (ja)
YU (1) YU124391A (ja)
ZA (1) ZA915372B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
US5153191A (en) * 1991-08-20 1992-10-06 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5399708A (en) * 1993-11-12 1995-03-21 Eli Lilly And Company Pyrazolidin-3-one derivatives
GB0011095D0 (en) * 2000-05-08 2000-06-28 Black James Foundation astrin and cholecystokinin receptor ligands (III)
IL156445A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
PE20020856A1 (es) * 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
UA79804C2 (en) 2002-07-03 2007-07-25 Janssen Pharmaceutica Nv Cck-1 receptor modulators
GB0312368D0 (en) * 2003-05-30 2003-07-02 Univ Aston Novel ureido- and amido-pyrazolone derivatives
US8410135B2 (en) * 2007-06-15 2013-04-02 Solvay Pharmaceuticals B.V. 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
BR112021009610A2 (pt) 2018-11-20 2021-08-10 Sironax Ltd composto, composição farmacêutica, uso de um composto ou composição, e, método de inibir necrose, ferroptose, rip1 humana ou indicações relacionadas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE530886A (ja) * 1953-08-03
FR82186E (fr) * 1959-04-10 1964-01-04 Kodak Pathe Nouveau produit photographique et procédé pour le traitement de ce produit
FR2529786A1 (fr) * 1982-07-12 1984-01-13 Nativelle Sa Ets Compositions pharmaceutiques a base de derives de la pyrazolone-5, nouveaux produits et procede de preparation
DE3407506A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoline, verfahren zu ihrer herstellung und deren verwendung
EP0166355A2 (en) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituted aminophenyl compounds and acylaminophenyl compounds and pharmaceutical compositions containing them
US5089622A (en) * 1988-12-12 1992-02-18 Mitsui Toatsu Chemicals Incorporated (-)-2-pyrazoline compounds and therapeutic agent for cerebrovascular disorders containing the same as effective ingredient
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents

Also Published As

Publication number Publication date
BR9103042A (pt) 1992-04-28
KR920002548A (ko) 1992-02-28
EP0467614A1 (en) 1992-01-22
HUT58296A (en) 1992-02-28
PT98323A (pt) 1992-06-30
AU8040991A (en) 1992-01-23
FI913431A0 (fi) 1991-07-16
JPH04230367A (ja) 1992-08-19
HU912376D0 (en) 1991-12-30
CN1058209A (zh) 1992-01-29
CN1032000C (zh) 1996-06-12
IL98785A (en) 1995-11-27
MX9100164A (es) 1992-02-28
IL98785A0 (en) 1992-07-15
NO912772D0 (no) 1991-07-15
AU5529394A (en) 1994-04-28
NZ238912A (en) 1992-12-23
RU2076100C1 (ru) 1997-03-27
IE912489A1 (en) 1992-01-29
AU644190B2 (en) 1993-12-02
KR960005950B1 (ko) 1996-05-06
CA2046672A1 (en) 1992-01-18
YU124391A (sh) 1994-01-20
ZA915372B (en) 1993-03-31
NO912772L (no) 1992-01-20
FI913431A7 (fi) 1992-01-18

Similar Documents

Publication Publication Date Title
AU643337B2 (en) Condensed heterocyclic compounds, their production and use
CA1174682A (en) Active compounds
Bergmann et al. Synthesis and antihypertensive activity of 4-(1, 2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators
Xiong et al. Synthesis of novel analogues of marine indole alkaloids: Mono (indolyl)-4-trifluoromethylpyridines and bis (indolyl)-4-trifluoromethylpyridines as potential anticancer agents
EP0411507B1 (en) Pyrazole derivatives, their production and use
DE3004370A1 (de) 1- eckige klammer auf (acylthio)- und (mercapto)-1-oxoalkyl eckige klammer zu -1,2,3,4-tetrahydrochinolin-2-carbonsaeuren
CA2054637A1 (en) Indane and quinoline derivatives
EP2961745A1 (en) Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
WO2001037826A1 (en) Npyy5 antagonists
WO2014134391A1 (en) Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
EP0797576A1 (en) Alkyl substituted piperadinyl and piperazinyl anti-aids compounds
CA3239394A1 (en) 4-phenyl-2-(1h-1,2,3-triazol-4-yl)piperidin-4-ol derivatives as inhibitors of apol1 and methods of using same
US5393771A (en) 4-substituted benzopyran and related compounds
Nayak et al. Green synthesis of spirooxindole-pyrrolidine/piperidine fused nitrochromane: One pot three component stereo and regioselective cycloaddition
NO149065B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
TW201307332A (zh) 製造旋轉酶及拓樸異構酶ｉｖ抑制劑之方法
NO852133L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.
Buehlmayer et al. Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives
Maurya et al. Regio-and stereoselective synthesis of novel spiropyrrolidines through 1, 3-dipolar cycloaddition reactions of azomethine ylides and 2-styrylquinazolin-4 (3 H)-ones
Bonnaud et al. Synthesis of novel isoquinoline derivatives as potential CNS‐agents
KR960005950B1 (ko) 피라졸리디논 cck 및 가스트린 길항물질 및 그의 약학 조성물
Bringmann et al. Synthesis of methylene-bridged binary carbazole alkaloids and a related tricarbazole
NO173865B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,3,4,5-tetrahydro-1h-3-benzazepiner
PL69663B1 (ja)
Alezra et al. Asymmetric synthesis of quaternary tetrahydroisoquinoline-3-carboxylic acid derivatives